Excitatory‐inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome

Down syndrome (DS) is a neurological disorder causing impaired learning and memory. Partial trisomy 16 mice (Ts65Dn) are a genetic model for DS. Previously, we demonstrated widespread alterations of pre‐ and postsynaptic elements and physiological abnormalities in Ts65Dn mice. The average diameter of presynaptic boutons and spines in the neocortex and hippocampus was enlarged. Failed induction of long‐term potentiation (LTP) due to excessive inhibition was observed. In this paper we investigate the morphological substrate for excessive inhibition in Ts65Dn. We used electron microscopy (EM) to characterize synapses, confocal microscopy to analyze colocalization of the general marker for synaptic vesicle protein with specific protein markers for inhibitory and excitatory synapses, and densitometry to characterize the distribution of the receptor and several proteins essential for synaptic clustering of neurotransmitter receptors. EM analysis of synapses in the Ts65Dn vs. 2N showed that synaptic opposition lengths were significantly greater for symmetric synapses (∼18%), but not for asymmetric ones. Overall, a significant increase in colocalization coefficients of glutamic acid decarboxylase (GAD)65/p38 immunoreactivity (IR) (∼27%) and vesicular GABA transporter (VGAT)/p38 IR (∼41%) was found, but not in vesicular glutamate transporter 1 (VGLUT1)/p38 IR. A significant overall decrease of IR in the hippocampus of Ts65Dn mice compared with 2N mice for glutamate receptor 2 (GluR2; ∼13%) and anti‐γ‐aminobutyric acid (GABA)A receptor β2/3 subunit (∼20%) was also found. The study of proteins essential for synaptic clustering of receptors revealed a significant increase in puncta size for neuroligin 2 (∼13%) and GABAA receptor‐associated protein (GABARAP; ∼13%), but not for neuroligin 1 and gephyrin. The results demonstrate a significant alteration of inhibitory synapses in the fascia dentata of Ts65Dn mice. J. Comp. Neurol. 512:453–466, 2009. © 2008 Wiley‐Liss, Inc.

[1]  P. Yates,et al.  Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. , 2008, Journal of mental deficiency research.

[2]  R. Carroll,et al.  NMDA Receptor Activation Potentiates Inhibitory Transmission through GABA Receptor-Associated Protein-Dependent Exocytosis of GABAA Receptors , 2007, The Journal of Neuroscience.

[3]  M. Dierssen,et al.  Fetal Down Syndrome Brains Exhibit Aberrant Levels of Neurotransmitters Critical for Normal Brain Development , 2007, Pediatrics.

[4]  C. Epstein,et al.  Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype‐phenotype relationships , 2007, The Journal of comparative neurology.

[5]  L. Riquelme,et al.  Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models , 2007, The European journal of neuroscience.

[6]  Colin J. Akerman,et al.  Refining the roles of GABAergic signaling during neural circuit formation , 2007, Trends in Neurosciences.

[7]  A. Penn,et al.  Molecular determinants of AMPA receptor subunit assembly , 2007, Trends in Neurosciences.

[8]  Chris J. McBain,et al.  The Role of the GluR2 Subunit in AMPA Receptor Function and Synaptic Plasticity , 2007, Neuron.

[9]  Caroline C Brown,et al.  Disordered connectivity in the autistic brain: challenges for the "new psychophysiology". , 2007, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[10]  G. Homanics,et al.  Compensatory alteration of inhibitory synaptic circuits in cerebellum and thalamus of γ‐aminobutyric acid type A receptor α1 subunit knockout mice , 2006 .

[11]  P. Scheiffele,et al.  Control of Excitatory and Inhibitory Synapse Formation by Neuroligins , 2005, Science.

[12]  C. Epstein,et al.  Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome , 2004, The Journal of comparative neurology.

[13]  R. Malenka,et al.  Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome , 2004, The Journal of Neuroscience.

[14]  C. Keller,et al.  Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. , 2004, Pharmacology & therapeutics.

[15]  J. Meier,et al.  A Gephyrin-Related Mechanism Restraining Glycine Receptor Anchoring at GABAergic Synapses , 2004, The Journal of Neuroscience.

[16]  M. Merzenich,et al.  Model of autism: increased ratio of excitation/inhibition in key neural systems , 2003, Genes, brain, and behavior.

[17]  F. Benes,et al.  GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder , 2001, Neuropsychopharmacology.

[18]  S. Rapoport,et al.  On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models , 2001, Brain Research Reviews.

[19]  N. Cairns,et al.  Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  C. Epstein,et al.  Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome , 2000, Pediatric Research.

[21]  R. Fremeau,et al.  Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. , 2000, Science.

[22]  R. Olsen,et al.  Binding of the GABAA Receptor‐Associated Protein (GABARAP) to Microtubules and Microfilaments Suggests Involvement of the Cytoskeleton in GABARAPGABAA Receptor Interaction , 2000 .

[23]  D. Davies,et al.  Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice , 2000, Brain Research.

[24]  C. Epstein,et al.  Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome , 1999, Neuropharmacology.

[25]  V. Meskenaite,et al.  GABAB‐receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization , 1999, The European journal of neuroscience.

[26]  K. Osen,et al.  The Vesicular GABA Transporter, VGAT, Localizes to Synaptic Vesicles in Sets of Glycinergic as Well as GABAergic Neurons , 1998, The Journal of Neuroscience.

[27]  M. Dierssen,et al.  Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome , 1998, Neuroscience Letters.

[28]  P. Yarowsky,et al.  Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice , 1998, Behavioural Brain Research.

[29]  S. Rapoport,et al.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome , 1997, Neuropharmacology.

[30]  N. Cairns,et al.  Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. , 1997, Life sciences.

[31]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[32]  G. Reynolds,et al.  Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue , 1988, Neuroscience Letters.

[33]  M. Casanova,et al.  Abnormalities of the nucleus basalis in Down's syndrome , 1985, Annals of neurology.

[34]  E. G. Gray,et al.  Electron Microscopy of Synaptic Contacts on Dendrite Spines of the Cerebral Cortex , 1959, Nature.

[35]  W. Mobley,et al.  Using mouse models to explore genotype-phenotype relationship in Down syndrome. , 2007, Mental retardation and developmental disabilities research reviews.

[36]  G. Homanics,et al.  Compensatory alteration of inhibitory synaptic circuits in cerebellum and thalamus of gamma-aminobutyric acid type A receptor alpha1 subunit knockout mice. , 2006, The Journal of comparative neurology.

[37]  Andrew J Trevelyan,et al.  Does inhibition balance excitation in neocortex? , 2005, Progress in biophysics and molecular biology.

[38]  Takao K Hensch,et al.  Excitatory-inhibitory balance and critical period plasticity in developing visual cortex. , 2005, Progress in brain research.

[39]  Robert Chen,et al.  Interactions between inhibitory and excitatory circuits in the human motor cortex , 2003, Experimental Brain Research.

[40]  R. Olsen,et al.  Binding of the GABA(A) receptor-associated protein (GABARAP) to microtubules and microfilaments suggests involvement of the cytoskeleton in GABARAPGABA(A) receptor interaction. , 2000, Journal of neurochemistry.